FDA OKs ADHD Generics; Flotation Therapy; Civilians Respond to Distress Calls

— News and commentary from the psychiatry world

Illustration of a brain shaped maze.

The FDA approved the first generic forms of lisdexamfetamine dimesylate (Vyvanse) capsules and chewables to treat attention deficit-hyperactivity disorder (ADHD) in patients 6 years and older, as well as moderate to severe binge-eating disorder in adults.

Hopefully this will ease the burden of the ADHD medication shortage as children head back to school. (CNBC)

Many psychiatrists in clinic are struggling to keep up with their electronic patient messages. (STAT)

In people with anorexia, twice-weekly, 60-minute flotation therapy sessions for a month helped decrease body dissatisfaction compared with usual care. (eClinicalMedicine)

From 2004 to 2019, rates of depressive disorders among kids remained stagnant. (JAMA Pediatrics)

Mothers who took selective serotonin reuptake inhibitors after giving birth experienced a benefit not only in their own depression, but also their child's externalizing problems and ADHD symptoms up to 5 years later. (JAMA Network Open)

Childless men -- an often forgotten group -- struggle with grief and loneliness. (The Guardian)

Mental health spending exploded during the pandemic, as telehealth options made care more accessible, a study in JAMA Health Forum found.

Clara Hill, PhD, the co-director of a now-closed Maryland psychology clinic connected to 18 retracted papers, has retired. (Spectrum)

Civilians answering mental health distress calls instead of police officers is becoming the norm in many big U.S. cities. (AP)

The national telepsychiatry provider Talkiatry expanded its child and adolescent psychiatry services to another five states. (Fierce Healthcare)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.